Want to see SE:ATIN full AI Analyst Report?
Athanase Innovation AB (ATIN) Financial Statements
Athanase Innovation AB Financial Overview
Athanase Innovation AB's market cap is currently $347.36M. The company's EPS TTM is $-2.30; its P/E ratio is -7.83; and it has a dividend yield of 56.54%. Athanase Innovation AB is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 36.86M | $ 176.83M | $ 40.60M | $ 6.38M | $ 7.06M |
| Gross Profit | $ -95.53M | $ 74.94M | $ 17.78M | $ -84.02M | $ -31.01M |
| Operating Income | $ -81.41M | $ -23.70M | $ -79.20M | $ -84.07M | $ -31.01M |
| EBITDA | $ -67.29M | $ 696.00K | $ -63.41M | $ -108.04M | $ -18.75M |
| Net Income | $ -57.62M | $ -19.64M | $ -56.26M | $ -114.53M | $ -26.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 245.39M | $ 310.64M | $ 457.25M | $ 644.36M | $ 746.92M |
| Total Assets | $ 481.31M | $ 551.97M | $ 683.18M | $ 827.25M | $ 918.70M |
| Total Debt | $ 0.00 | $ 0.00 | $ 328.00K | $ 422.00K | $ 515.00K |
| Net Debt | $ -245.39M | $ -310.64M | $ -456.92M | $ -638.86M | $ -746.40M |
| Total Liabilities | $ 53.90M | $ 67.20M | $ 49.09M | $ 35.36M | $ 11.30M |
| Stockholders' Equity | $ 427.20M | $ 484.76M | $ 634.09M | $ 791.89M | $ 907.40M |
| Cash Flow | |||||
| Free Cash Flow | $ -67.46M | $ -14.96M | $ -83.58M | $ -45.70M | $ -14.95M |
| Operating Cash Flow | $ -65.63M | $ -14.96M | $ -83.40M | $ -43.65M | $ -14.89M |
| Investing Cash Flow | $ -2.79M | $ -1.49M | $ 5.90M | $ -64.98M | $ -159.47M |
| Financing Cash Flow | $ 3.20M | $ -129.63M | $ -101.84M | $ -1.03M | $ 920.80M |
Currency in SEK